Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Silicate ions are small, inorganic anions derived from the dissolution of silicate-containing solids such as glasses, ceramics, or minerals in aqueous environments[2][6]. In the context of biomaterials, controlled silicate ion release can promote biological functions such as the proliferation and differentiation of osteoblasts and angiogenesis, mainly by mimicking hypoxic conditions and stabilizing hypoxia-inducible factors (HIF), or enhancing the expression of growth factors like VEGF in endothelial cells[3][4]. These effects make silicate ion-releasing materials attractive for bone repair, tissue engineering, and regenerative medicine. However, "silicate ion release" itself is not a molecular target but a chemical process, and the silicate ion is not a druggable protein, receptor, or enzyme.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Silicate ion (null).